Galway firm secure licensing deal for 'drug delivery' patch

HP and Crospon, a medical device developer based in Galway, Ireland, today announced they have entered a licensing agreement for a drug delivery platform that enables painless, controlled release of one or more drugs in a single patch applied to the skin.

Under the agreement, HP will license its intellectual property to Crospon in return for royalty payments. Crospon will commercialise the patch, which was invented by HP Labs, the company’s central research facility, and make it available to pharmaceutical companies to use in various therapeutic areas.